PTGS2 and Dysmenorrhea: Dysmenorrhea may be related to nitric oxide (NO) [40] where XGDP can reduce NO levels through the calcium signaling pathway and arginine and proline metabolism, whereas the PTGS2 is the target for NSAIDs and PTGS2 (COX-2) specific inhibitors called coxibs for dysmenorrhea [41].